Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring.

Source:http://linkedlifedata.com/resource/pubmed/id/16497825

Download in:

View as

General Info

PMID
16497825